News, musings and commentary on pharmaceutical law issues, technology, and litigation.
No advice, though.
Lawyers for consumers and injured people.(No advice on this blog, though) TOLL FREE 855-525-3955
Friday, February 02, 2007
FDA Slaps Drug Co. Ad's Misleading
The FDA claims that MGI Pharma published a "misleading" advertisement for the company's implanted therapy to treat brain tumors.
A two-page promotional ad for the product, called gliadel wafer, does not disclose its full indication and presents unsubstantiated claims, according to the FDA.